维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Daniel F.Martin"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion显示文摘AIM: To compare the efficacy of ranibizumab and bevacizumab for macular edema due to retinal vein occlusion(RVO). ·METHODS: A retrospective study was conducted at a single academic institution. Eighty-one patients na觙ve to anti-VEGF therapy with RVO and macular edema were identified. Twenty-six eyes were treated with ranibizumab,33 eyes with bevacizumab,and 22 eyes with bevacizumab then switched to ranibizumab(crossover). The main outcome was change in visual acuity at 3 months,6 months,and final visit. ·RESULTS: The mean visual acuity improved from 20/80 to 20/40 in the ranibizumab(R) group and from 20/125 to 20/60 in the bevacizumab(B) group(P =0.66). The mean change in central subfield thickness(CST) was-186 and 212μm,respectively(P =0.69). Mean time between injections was 94±21.1d in the R group and 103.8 ±10.5d in the B group(P =0.78). In the crossover group,mean initial visual acuity was 20/125,reached 20/60 at crossover,and remained 20/60 at conclusion(P =0.91). ·CONCLUSION: Both ranibizumab and bevacizumab are effective for the treatment of RVO and appear to have similar visual and anatomic outcomes. Changing treatments from bevacizumab to ranibizumab did not result in further gains in visual acuity.	Alex Yuan Baseer U.Ahmad David Xu Rishi P.Singh Peter K.Kaiser Daniel F.Martin Jonathan E.Sears Andrew P.Schachat Justis P.Ehlers	2014	International Journal of Ophthalmology(English edition)2014，7，1：	4

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费